Oramed Pharmaceuticals
ORMP
#9022
Rank
NZ$0.21 B
Marketcap
NZ$5.38
Share price
-3.55%
Change (1 day)
39.68%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$24.87 Million a decrease over its 2023 earnings that were of NZ$11.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-497.61%
2024 -NZ$24.87 Million-311.47%
2023 NZ$11.75 M-119.45%
2022 -NZ$60.44 Million39.17%
2021 -NZ$43.43 Million73.93%
2020 -NZ$24.97 Million18.53%
2019 -NZ$21.07 Million-16.62%
2018 -NZ$25.27 Million38.32%
2017 -NZ$18.27 Million12.51%
2016 -NZ$16.24 Million25.01%
2015 -NZ$12.99 Million18.18%
2014 -NZ$10.99 Million39.72%
2013 -NZ$7.87 Million46.4%
2012 -NZ$5.38 Million128.32%
2011 -NZ$2.36 Million-51.47%
2010 -NZ$4.85 Million35.21%
2009 -NZ$3.59 Million
2007 -NZ$5.64 Million607.04%
2006 -NZ$0.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$34.07 B 35,325.54%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$15.01 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.86 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$45.48 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel